These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25501980)

  • 1. The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection.
    Jacquemyn Y; Zecic A; Van Laere D; Roelens K
    Arch Gynecol Obstet; 2015 May; 291(5):969-75. PubMed ID: 25501980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
    McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
    Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium and the obstetric anaesthetist.
    Dean C; Douglas J
    Int J Obstet Anesth; 2013 Jan; 22(1):52-63. PubMed ID: 23182610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of magnesium sulfate in obstetrics].
    Kayem G; Mandelbrot L; Haddad B
    Gynecol Obstet Fertil; 2012 Oct; 40(10):605-13. PubMed ID: 22995056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
    Obstet Gynecol; 2010 Mar; 115(3):669-671. PubMed ID: 20177305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
    Marret S; Chollat C; Levèque C; Marpeau L
    Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
    Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
    BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm labor: approach to decreasing complications of prematurity.
    Locatelli A; Consonni S; Ghidini A
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.
    De Silva DA; Synnes AR; von Dadelszen P; Lee T; Bone JN; ; Magee LA
    Implement Sci; 2018 Jan; 13(1):8. PubMed ID: 29325592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
    Ow LL; Kennedy A; McCarthy EA; Walker SP
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
    Mittendorf R; Roizen NJ; Pryde PG
    J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnesium sulfate during anticipated preterm birth for infant neuroprotection.
    Merrill L
    Nurs Womens Health; 2013; 17(1):42-51. PubMed ID: 23399012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.